SevenBridge Financial Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,535
Closed -$265K 160
2021
Q4
$265K Hold
4,535
0.08% 148
2021
Q3
$269K Sell
4,535
-12,195
-73% -$723K 0.09% 141
2021
Q2
$1.45M Buy
16,730
+13,482
+415% +$1.17M 0.47% 64
2021
Q1
$268K Buy
3,248
+122
+4% +$10.1K 0.1% 136
2020
Q4
$284K Buy
+3,126
New +$284K 0.11% 130